BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7540219)

  • 1. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
    Misawa S; Tsuda S; Taniwaki M; Horiike S; Ariyama Y; Hirakawa K; Ueda Y; Kaneko H; Nakao M; Kashima K
    Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of fosfomycin in combination with sulbactam/cefoperazone in the treatment of severe infections complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBT/CPZ].
    Kitamura K; Hirai H; Hosoya N; Sugai M; Karasawa M; Naruse T; Miura Y; Ohmine K; Takagi S; Hirashima K; Bessho M; Fukuda M; Kawai N; Dan K; Ann E; Hoshino T; Oshimi K; Noguchi M; Egashira M; Ikeda Y; Kizaki M; Toyama K; Miyazawa K; Nagasu M; Hirasawa A
    Kansenshogaku Zasshi; 1998 Jul; 72(7):761-70. PubMed ID: 9745228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Kitamura K; Takaku F; Miyazaki T; Miura ; Mizoguchi H; Saito H; Masaoka T; Kimura I; Niho Y
    Jpn J Antibiot; 1991 Sep; 44(9):979-86. PubMed ID: 1960859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
    Ohno R; Hotta T; Ogura M; Ohnishi K; Morishita T; Murate T; Okumura M; Tanimoto M; Inoue C; Hamaguchi M
    Jpn J Antibiot; 1989 Aug; 42(8):1713-9. PubMed ID: 2810734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M; Hirashima K
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An evaluation of combination antibiotic therapy in infections with hematological disorders. Hyogo Cooperative Study Group of Infectious Diseases Complicating Hematological Disorders].
    Takemoto Y; Kanamaru A; Kakishita E; Nakayama S; Hara H; Yamaguchi N; Tsutsui T; Mitsutani S; Tago H; Sonoda T
    Jpn J Antibiot; 1991 Mar; 44(3):296-302. PubMed ID: 1880911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
    Sukoh M; Inoue T; Morita Y; Ito K; Togano Y; Yamanaka K; Hirose S; Takahashi T; Mita S; Mano K
    Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sulbactam/cefoperazone for the treatment of infections in patients with hematologic diseases.
    Horiuchi A; Hasegawa H; Kageyama T; Yonezawa T; Kitani T; Masaoka T; Yasunaga K; Kawagoe H; Nagai K
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):215S-219S. PubMed ID: 2686922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders].
    Fujii Y; Ayame H; Inoue H; Fujita N; Miyoshi K; Murano K; Hatao K; Yaga K; Kaku K; Kaneko T
    Jpn J Antibiot; 1990 Jun; 43(6):1143-51. PubMed ID: 2232145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Toyama K; Torii Y; Aoki I; Kikuchi M; Wakasugi K
    Jpn J Antibiot; 1992 Aug; 45(8):1003-8. PubMed ID: 1433888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders].
    Seriu T; Tsuda S; Nakai H; Murakami T; Takashima T; Takahashi Y; Tanaka S; Nakagawa H; Nishigaki H; Yokota S
    Jpn J Antibiot; 1991 Nov; 44(11):1197-205. PubMed ID: 1784070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
    Kawai Y; Ueda T; Iwasaki H; Nakamura T
    Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
    Hirakawa K; Tsuda S; Misawa S; Ueda Y; Kaneko H; Nakao M; Ariyama Y; Nakai H; Seriu T; Takashima T
    Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
    Akutsu I; Motojima S; Sagara H; Ogata H; Otsuka T; Fukuda T; Ikemori R; Makino S
    Jpn J Antibiot; 1989 Apr; 42(4):910-20. PubMed ID: 2769942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Obata I; Ryu F; Imagawa N; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1984 Dec; 37(12):2478-94. PubMed ID: 6098741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Yabuki Y; Asamoto A; Hoshiba T
    Jpn J Antibiot; 1984 Oct; 37(10):1973-6. PubMed ID: 6094876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multicenter study of the effects of sulbactam/cefoperazone on bacterial infections in the fields of internal medicine focused mainly on respiratory infections in Tochigi Prefecture].
    Motojima S; Asakawa J; Ezure M; Tateishi K; Nakajima H; Hirata S; Sagara H; Arima M; Akutsu I; Fukuda T
    Jpn J Antibiot; 1993 Oct; 46(10):918-25. PubMed ID: 8254894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.